Note: Ingredients listed on restricted chemical lists
EC/CAS
207-838-8/497-19-8
Name of the chemical
Sodium carbonate
Concentration
10 - 30
EC/CAS
932-051-8/68411-30-3
Name of the chemical
Benzenesulfonic acid,C10-13-alkyl derivs., sodium salts
Concentration
1 - 3
General Information
Version
1.1
Revision date
2025-08-01
Product name
CARETEX Powder Ultra
1.2.1 Relevant identified uses
Professional use
1.2.2. Uses advised against
The product should not be used for purposes other than those shown above without first referring to the supplier and obtaining written handling instructions
Manufacturer Name
Christeyns NV
Emergency telephone
+353 1 809 2566, +353 1 809 2166, 0344 892 0111
Icons in SDS
Company Information
company name
Christeyns NV
e-mail address of the competent person responsible for the Safety Data Sheet
info@christeyns.be, info@christeyns.ie, UK-foodinfo@christeyns.com, info.cph.uk@christeyns.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS05
Signal word
Danger
Contains
Alcohol ethoxylate; Sodium disilicate; Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs. and benzenesulfonic acid, 4-methyl-, reaction products with sodium hydroxide; Sodium percarbonate
Hazard statements
H318 - Causes serious eye damage.
Precautionary statements
P280 - Wear eye protection. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor.
Other hazards which do not result in classification
None under normal conditions. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
H318 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP]
